ReviewCurrent oncology reports2009

VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy.

C Lance Cowey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.